MEEDER ASSET MANAGEMENT INC - AIMMUNE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$11,000
-99.4%
475
+569.0%
0.00%
Q2 2018$1,909,000
+11831.2%
71
-86.1%
0.00%
-100.0%
Q1 2018$16,000
-15.8%
512
+1.4%
0.00%
-50.0%
Q4 2017$19,000
+533.3%
505
+282.6%
0.00%
Q1 2017$3,0001320.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders